Nanofluidic digital PCR for improved selection of metastatic colorectal cancer patients to anti-EGFR therapies

被引：0
作者：
Azuara, D. [1 ]
Santos, C. [1 ,2 ]
Lopez-Doriga, A. [3 ]
Montal, R. [1 ,2 ]
Sanjuan, X. [4 ]
Moreno, V. [3 ]
Tabernero, J. [5 ]
Montagut, C. [6 ]
Salazar, R. [1 ,2 ]
Capella, G. [1 ]
机构：
[1] Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain
[2] Catalan Inst Oncol IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain
[3] Catalan Inst Oncol IDIBELL, Biomarkers & Susceptibil Unit, Lhospitalet De Llobregat, Spain
[4] Univ Hosp Bellvitge IDIBELL, Dept Pathol, Lhospitalet De Llobregat, Spain
[5] Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain
[6] Hosp del Mar, Dept Med Oncol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
699
引用
收藏
页码：S154 / S155
页数：2
相关论文
共 50 条
  • [41] Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
    Di Fiore, F.
    Sesbouee, R.
    Michel, P.
    Sabourin, J. C.
    Frebourg, T.
    BRITISH JOURNAL OF CANCER, 2010, 103 (12) : 1765 - 1772
  • [42] Drivers of secondary resistance to anti-EGFR therapy in metastatic colorectal cancer
    Noseir, Soha Hussein
    Hahn, Stephan
    Maghnouj, Abdelouahid
    Ladigan, Swetlana
    CANCER RESEARCH, 2020, 80 (16)
  • [43] Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
    Lo Nigro, Cristiana
    Ricci, Vincenzo
    Vivenza, Daniela
    Granetto, Cristina
    Fabozzi, Teresa
    Miraglio, Emanuela
    Merlano, Marco C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (30) : 6944 - 6954
  • [44] MicroRNAs and response to anti-EGFR therapy in metastatic colorectal cancer.
    Blanco-Calvo, Moises
    Haz-Conde, Mar
    Rodriguez-Rigueiro, Teresa
    Figueroa, Angelica
    Reboredo, Margarita
    Medina Villaamil, Vanessa
    Lorenzo-Patino, Maria J.
    Arnal, Francisco
    Anton-Aparicio, Luis
    Alonso-Jaudenes Curbera, Guillermo
    Valladares-Ayerbes, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Drivers of Secondary Resistance to Anti-Egfr Therapy in Metastatic Colorectal Cancer
    Noseir, Soha
    Hahn, Stephan
    Maghnouj, Abdelonahid
    Ladigan, Swetlana
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 219 - 219
  • [46] Management of Toxicity Induced by Anti-EGFR Therapy in Metastatic Colorectal Cancer
    Rolfo, Christian
    Bronte, Giuseppe
    Passiglia, Francesco
    Papadimitriou, Konstantinos
    Russo, Antonio
    Peeters, Marc
    CURRENT COLORECTAL CANCER REPORTS, 2013, 9 (03) : 250 - 260
  • [47] Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
    Bardelli, Alberto
    Corso, Simona
    Bertotti, Andrea
    Hobor, Sebastijan
    Valtorta, Emanuele
    Siravegna, Giulia
    Sartore-Bianchi, Andrea
    Scala, Elisa
    Cassingena, Andrea
    Zecchin, Davide
    Apicella, Maria
    Migliardi, Giorgia
    Galimi, Francesco
    Lauricella, Calogero
    Zanon, Carlo
    Perera, Timothy
    Veronese, Silvio
    Corti, Giorgio
    Amatu, Alessio
    Gambacorta, Marcello
    Diaz, Luis A., Jr.
    Sausen, Mark
    Velculescu, Victor E.
    Comoglio, Paolo
    Trusolino, Livio
    Di Nicolantonio, Federica
    Giordano, Silvia
    Siena, Salvatore
    CANCER DISCOVERY, 2013, 3 (06) : 658 - 673
  • [48] Liquid biopsy-driven anti-EGFR rechallenge in patients with metastatic colorectal cancer.
    Mariani, Stefano
    Puzzoni, Marco
    Liscia, Nicole
    Impera, Valentino
    Pretta, Andrea
    Tolu, Simona
    Pireddu, Anna Grazia
    Persano, Mara
    Musio, Francesca
    Donisi, Clelia
    Pinna, Giovanna
    Lai, Eleonora
    Demurtas, Laura
    Ziranu, Pina
    Pusceddu, Valeria
    Pisano, Marina
    Palomba, Grazia
    Casula, Milena
    Palmieri, Giuseppe
    Scartozzi, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Biomarker selection of liver metastatic colorectal patients for anti-EGFR monoclonal antibodies: A machine learning analysis
    Chen, Y.
    Chang, W.
    Wei, Y.
    Xu, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)
    S. Abdelwahab
    A. Azmy
    H. Abdel-aziz
    H. Salim
    A. Mahmoud
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1487 - 1492
12345